AnalystLens
Stocks
REGENERON PHARMACEUTICALS, INC.
Healthcare
Cash Flow
Debt Repayment
Search...
⌘K
Stocks
Sectors
Log in
Sign up
Income Statement
Balance Sheet
Cash Flow
Per Share
Back to REGN
REGENERON PHARMACEUTICALS, INC. Debt Repayment 2016-2017 | REGN
Beta
No annual data available.
Debt Repayment History
Annual
Quarterly
Period
Value
Change · QoQ
Source
Q1 FY2017
$12.9M
+2050.7%
10-Q
Q1 FY2016
$598,000
-
10-Q
All REGENERON PHARMACEUTICALS, INC. (REGN) Financial Metrics
Income Statement
Revenue
Cost of Revenue
Gross Profit
R&D
SG&A
Total OpEx
Operating Income
Interest Expense
Non-op Income
Pre-tax Income
Income Tax
Net Income
Comprehensive Income
EPS (Basic)
EPS (Diluted)
Balance Sheet
Cash & ST Investments
Total Assets
Current Assets
Cash
Short-Term Investments
Receivables
Inventory
Prepaid & Other
PP&E
Intangibles
Other Non-current
Total Liabilities
Current Liabilities
Accounts Payable
Accrued Liabilities
Short-Term Debt
Deferred Revenue
Long-Term Debt
Other Non-current Liab.
Equity
Retained Earnings
Accumulated OCI
APIC
Treasury Stock
Total L&E
Shares Outstanding
Cash Flow
Operating Cash Flow
D&A
SBC
Deferred Tax
Investing Cash Flow
Acquisitions
Financing Cash Flow
Debt Issuance
Debt Repayment
Stock Issuance
Buybacks
Dividends Paid
Net Change in Cash
Per Share
EPS (Basic)
EPS (Diluted)
Dividends/Share
Shares Basic
Shares Diluted
Company:
REGENERON PHARMACEUTICALS, INC.
Ticker:
REGN
Sector:
Healthcare
Industry:
Pharmaceutical Preparations
View company profile →